Skip to content

Author

B. Ethiraj

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Integrating machine learning and structure-based simulations to prioritise Z4P as a mutation-resilient IRE1α inhibitor for breast cancer.

Findings highlight Z4P as a promising mutation-resilient IRE1 inhibitor and validate the effectiveness of the integrated computational pipeline for identifying potential anti-cancer therapeutics.

Nithisha L Bastin, P. K. Praveen Kumar, B. Ethiraj et al. · 0 citations